news & events




April 2018

Berberine derivatives are present at IX WDD-2018 Congress

Dr. Paolo Lombardi, CEO of Naxospharma and former collaborator of AROMICS will present the advances of Berberine and novel derivatives as therapy for treating cancer. Dr. Lombardi is one of the participants of the World DNA Day, the most influential congress that BIT organized in the past 14 years. The aim of BIT's 9th...


March 2018

AROMICS to participate at the annual meeting of the International Mesothelioma Group iMig in Ottawa, Canada

AROMICS will be present on the 14th meeting of the International Mesothelioma Interest Group (iMig 2018) to be held in Ottawa, Canada in May 2018. During the congress the company will present new data with the compound NAX035, on the mechanism of action and preclinical efficacy in experimental models of mesothelioma. The work presented...


January 2018

METACAN project launches its web

AROMICS is one of the participants of the METACAN european  research project. This training network provides a pan-European interdisciplinary and intersectoral training programme of excellence bringing young researchers together with world-leading academics,...


December 2017

AROMICS partipates at the SME Capital Forum

Closing the year with the company presentacion at the 32 editiion of SME Capital Forum organized at Bolsa de Madrid.

3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11